Adenosine triphosphate stimulates RANKL expression through P2Y1 receptor-cyclo-oxygenase-dependent pathway in human periodontal ligament cells

Journal of Periodontal Research

Volumn 45, Issue 3, 2010, Pages 404-411

  Luckprom, P ^a   Wongkhantee, S ^b   Yongchaitrakul, T ^a   Pavasant, P ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Adenosine triphosphate; Cyclo oxygenase; P2Y1 receptor; Periodontal ligament; Receptor activator of nuclear factor B ligand

Indexed keywords

1 (6 ((3 METHOXYESTRA 1,3,5(10) TRIEN 17 YL)AMINO)HEXYL) 1H PYRROLE 2,5 DIONE; 1-(6-((3-METHOXYESTRA-1,3,5(10)-TRIEN-17-YL)AMINO)HEXYL)-1H-PYRROLE-2,5-DIONE; 2 PYRROLIDONE DERIVATIVE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DRUG DERIVATIVE; ENZYME INHIBITOR; ESTRANE DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOMETACIN; ISOQUINOLINE DERIVATIVE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; N(6) METHYL 2' DEOXYADENOSINE 3',5' DIPHOSPHATE; N(6)-METHYL-2'-DEOXYADENOSINE 3',5'-DIPHOSPHATE; OSTEOCLAST DIFFERENTIATION FACTOR; PHOSPHODIESTERASE INHIBITOR; PHOSPHOLIPASE C; PROSTAGLANDIN E2; PURINERGIC P2 RECEPTOR; PURINERGIC P2Y1 RECEPTOR; PYRROLIDINE DERIVATIVE; PYRROLIDINE DITHIOCARBAMIC ACID; SMALL INTERFERING RNA; SULFONAMIDE; THIOCARBAMIC ACID DERIVATIVE; N-(2-(4-BROMOCINNAMYLAMINO)ETHYL)-5-ISOQUINOLINESULFONAMIDE; P2RY1 PROTEIN, HUMAN; PURINERGIC P2 RECEPTOR ANTAGONIST;

ARTICLE; BIOMECHANICS; BONE REMODELING; CELL CULTURE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENETICS; HUMAN; METABOLISM; OSTEOLYSIS; PATHOPHYSIOLOGY; PERIODONTAL LIGAMENT; PHYSIOLOGY; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS;

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; BIOMECHANICS; BONE REMODELING; BONE RESORPTION; CELLS, CULTURED; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DINOPROSTONE; ENZYME INHIBITORS; ESTRENES; HUMANS; INDOMETHACIN; ISOQUINOLINES; NF-KAPPA B; PERIODONTAL LIGAMENT; PHOSPHODIESTERASE INHIBITORS; PYRROLIDINES; PYRROLIDINONES; RANK LIGAND; RECEPTORS, PURINERGIC P2; RNA, SMALL INTERFERING; SULFONAMIDES; THIOCARBAMATES; TYPE C PHOSPHOLIPASES; BIOMECHANICAL PHENOMENA; PURINERGIC P2 RECEPTOR ANTAGONISTS; RECEPTORS, PURINERGIC P2Y1;

EID: 77953172304     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2009.01256.x     Document Type: Article

References (26)

1. Ferguson DR, Kennedy I, Burton TJ. ATP is released from rabbit urinary bladder epithelial cells by hydrostatic pressure changes-a possible sensory mechanism? J Physiol 1997, 505:503-511.
2. Knight GE, Burnstock G. The effect of pregnancy and the oestrus cycle on purinergic and cholinergic responses of the rat urinary bladder. Neuropharmacology 2004, 46:1049-1056.
3. Hazama A, Shimizu T, Ando-Akatsuka Y. Swelling-induced, CFTR- independent ATP release from a human epithelial cell line: lack of correlation with volume-sensitive cl(-) channels. J Gen Physiol 1999, 114:525-533.
4. Grygorczyk R, Hanrahan JW. CFTR-independent ATP release from epithelial cells triggered by mechanical stimuli. Am J Physiol 1997, 272:1058-1066.
5. Sabirov RZ, Dutta AK, Okada Y. Volume-dependent ATP-conductive large-conductance anion channel as a pathway for swelling-induced ATP release. J Gen Physiol 2001, 118:251-266.
6. Burrell HE, Wlodarski B, Foster BJ. Human keratinocytes release ATP and utilize three mechanisms for nucleotide interconversion at the cell surface. J Biol Chem 2005, 280:29667-29676.
7. Fitz JG. Regulation of cellular ATP release. Trans Am Clin Climatol Assoc 2007, 118:199-208.
8. Fredholm BB, Abbracchio MP, Burnstock G. Towards a revised nomenclature for P1 and P2 receptors. Trends Pharmacol Sci 1997, 18:79-82.
9. Buckley KA, Hipskind RA, Gartland A, Bowler WB, Gallagher JA. Adenosine triphosphate stimulates human osteoclast activity via upregulation of osteoblast-expressed receptor activator of nuclear factor-kappa B ligand. Bone 2002, 31:582-590.
10. Morrison MS, Turin L, King BF, Burnstock G, Arnett TR. ATP is a potent stimulator of the activation and formation of rodent osteoclasts. J Physiol 1998, 511:495-500.
11. Bowler WB, Littlewood-Evans A, Bilbe G, Gallagher JA, Dixon CJ. P2Y2 receptors are expressed by human osteoclasts of giant cell tumor but do not mediate ATP-induced bone resorption. Bone 1998, 22:195-200.
12. Kanzaki H, Chiba M, Shimizu Y, Mitani H. Periodontal ligament cells under mechanical stress induce osteoclastogenesis by receptor activator of nuclear factor kappaB ligand up-regulation via prostaglandin E2 synthesis. J Bone Miner Res 2002, 17:210-220.
13. Yamaguchi M, Aihara N, Kojima T, Kasai K. RANKL increase in compressed periodontal ligament cells from root resorption. J Dent Res 2006, 85:751-756.
14. Wongkhantee S, Yongchaitrakul T, Pavasant P. Mechanical stress induces osteopontin expression in human periodontal ligament cells through rho kinase. J Periodontol 2007, 78:1113-1119.
15. Wongkhantee S, Yongchaitrakul T, Pavasant P. Mechanical stress induces osteopontin via ATP/P2Y1 in periodontal cells. J Dent Res 2008, 87:564-568.
16. Kim JM, Jeong D, Kang HK, Jung SY, Kang SS, Min BM. Osteoclast precursors display dynamic metabolic shifts toward accelerated glucose metabolism at an early stage of RANKL-stimulated osteoclast differentiation. Cell Physiol Biochem 2007, 20:935-946.
17. Hashimoto N, Watanabe T, Shiratori Y. Prostanoid secretion by rat hepatic sinusoidal endothelial cells and its regulation by exogenous adenosine triphosphate. Hepatology 1995, 21:1713-1718.
18. Xu J, Chalimoniuk M, Shu Y. Prostaglandin E2 production in astrocytes: regulation by cytokines, extracellular ATP, and oxidative agents. Prostaglandins Leukot Essent Fatty Acids 2003, 69:437-448.
19. Ruan YC, Wang Z, Du JY. Regulation of smooth muscle contractility by the epithelium in rat vas deferens: role of ATP-induced release of PGE2. J Physiol 2008, 586:4843-4857.
20. Korcok J, Raimundo LN, Du X, Sims SM, Dixon SJ. P2Y6 nucleotide receptors activate NF-kappaB and increase survival of osteoclasts. J Biol Chem 2005, 280:16909-16915.
21. Jung YJ, Isaacs JS, Lee S, Trepel J, Neckers L. IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB J 2003, 17:2115-2117.
22. Bucheimer RE, Linden J. Purinergic regulation of epithelial transport. J Physiol 2004, 555:311-321.
23. Hoebertz A, Arnett TR, Burnstock G. Regulation of bone resorption and formation by purines and pyrimidines. Trends Pharmacol Sci 2003, 24:290-297.
24. Korcok J, Raimundo LN, Ke HZ, Sims SM, Dixon SJ. Extracellular nucleotides act through P2X7 receptors to activate NF-kappaB in osteoclasts. J Bone Miner Res 2004, 19:642-651.
25. Nakamura E, Uezono Y, Narusawa K. ATP activates DNA synthesis by acting on P2X receptors in human osteoblast-like MG-63 cells. Am J Physiol Cell Physiol 2000, 279:C510-C519.
26. Nakao K, Goto T, Gunjigake KK, Konoo T, Kobayashi S, Yamaguchi K. Intermittent force induces high RANKL expression in human periodontal ligament cells. J Dent Res 2007, 86:623-628.